Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design

References

• Miyachi Y. Photoaging from an oxidative standpoint. J Dermatol Sci. 1995;9(2):79–86.7772578
   PubMed Web of Science ®Google Scholar
• Masaki H. Role of antioxidants in the skin: anti-aging effects. J Dermatol Sci. 2010;58(2):85–90. doi:10.1016/j.jdermsci.2010.03.00320399614
   PubMed Web of Science ®Google Scholar
• Wang CZ, Zhang Z, Wan JY, et al. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer. Nutrients. 2015;7(2):799–814. doi:10.3390/nu702079925625815
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Z, Wu X, et al. TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol. J Pharmacol Sci. 2015;127(1):83–91. doi:10.1016/j.jphs.2014.11.00325704023
   PubMedGoogle Scholar
• Xu C, Teng J, Chen W, et al. 20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(8):1402–1411. doi:10.1016/j.pnpbp.2010.07.01020647027
   PubMed Web of Science ®Google Scholar
• Yang Y, Lee J, Rhee MH, et al. Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions. J Ginseng Res. 2015;39(1):61–68. doi:10.1016/j.jgr.2014.06.00225535478
   PubMedGoogle Scholar
• Han S, Lim TG, Kim JE, et al. The ginsenoside derivative 20(S)-protopanaxadiol inhibits solar ultraviolet light-induced matrix metalloproteinase-1 expression. J Cell Biochem. 2017;118(11):3756–3764. doi:10.1002/jcb.2602328379603
   PubMedGoogle Scholar
• Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Monkkonen J. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci. 1999;7(4):279–286.9971910
   PubMed Web of Science ®Google Scholar
• Maniyar MG, Kokare CR. Formulation and evaluation of spray dried liposomes of lopinavir for topical application. J Pharm Investig. 2018;49:1–12.
   Google Scholar
• Balguri SP, Adelli GR, Majumdar S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm. 2016;109:224–235. doi:10.1016/j.ejpb.2016.10.01527793755
   PubMed Web of Science ®Google Scholar
• Beloqui A, Solinis MA, Rodriguez-Gascon A, Almeida AJ, Preat V. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomed-Nanotechnol. 2016;12(1):143–161. doi:10.1016/j.nano.2015.09.004
   PubMed Web of Science ®Google Scholar
• Mohammadi-Samani S, Zojaji S, Entezar-Almahdi E. Piroxicam loaded solid lipid nanoparticles for topical delivery: preparation, characterization and in vitro permeation assessment. J Drug Deliv Sci Tec. 2018;47:427–433. doi:10.1016/j.jddst.2018.07.015
   Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1–2):121–128. doi:10.1016/s0378-5173(02)00180-112176234
   PubMed Web of Science ®Google Scholar
• Nnamani PO, Hansen S, Windbergs M, Lehr CM. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Int J Pharm. 2014;477(1–2):208–217. doi:10.1016/j.ijpharm.2014.10.00425290810
   PubMed Web of Science ®Google Scholar
• Pokharkar V, Patil-Gadhe A, Kaur G. Physicochemical and pharmacokinetic evaluation of rosuvastatin loaded nanostructured lipid carriers: influence of long-and medium-chain fatty acid mixture. J Pharm Invest. 2018;48:1–12.
   Google Scholar
• Lasoń E, Sikora E, Miastkowska M, Socha P, Ogonowski J. NLC delivery systems for alpha lipoic acid: physicochemical characteristics and release study. Colloids Surf A. 2017;532:57–62. doi:10.1016/j.colsurfa.2017.06.083
   Web of Science ®Google Scholar
• Muller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59(6):522–530. doi:10.1016/j.addr.2007.04.01217602783
   PubMed Web of Science ®Google Scholar
• Hao J, Fang X, Zhou Y, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine. 2011;6:683–692. doi:10.2147/IJN.S1738621556343
   PubMed Web of Science ®Google Scholar
• Ravi PR, Aditya N, Kathuria H, Malekar S, Vats R. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm. 2014;87(1):114–124. doi:10.1016/j.ejpb.2013.12.01524378615
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485(1–2):235–243. doi:10.1016/j.ijpharm.2015.03.02025773359
   PubMed Web of Science ®Google Scholar
• Ranch KM, Maulvi FA, Naik MJ, Koli AR, Parikh RK, Shah DO. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: in vitro, ex vivo, in vivo and human studies. Int J Pharm. 2019;554:264–275. doi:10.1016/j.ijpharm.2018.11.01630423418
   PubMed Web of Science ®Google Scholar
• Salunkhe SS, Bhatia NM, Pokharkar VB, Thorat JD, Bhatia MS. Topical delivery of Idebenone using nanostructured lipid carriers: evaluations of sun-protection and anti-oxidant effects. J Pharm Investig. 2013;43(4):287–303. doi:10.1007/s40005-013-0079-y
   Google Scholar
• Lee SE, Lee JK, Jang WS, et al. Enhancement of stability and controlled drug release of lipid nanoparticles by modified solvent-evaporation method. Colloid Surf A. 2016;508:294–300. doi:10.1016/j.colsurfa.2016.08.043
   Google Scholar
• Kim KT, Kim MH, Park JH, et al. Microemulsion-based hydrogels for enhancing epidermal/dermal deposition of topically administered 20(S)-protopanaxadiol: in vitro and in vivo evaluation studies. J Ginseng Res. 2018;42(4):512–523. doi:10.1016/j.jgr.2017.07.00530337812
   PubMed Web of Science ®Google Scholar
• Jee JP, Pangeni R, Jha SK, Byun Y, Park JW. Preparation and in vivo evaluation of a topical hydrogel system incorporating highly skin-permeable growth factors, quercetin, and oxygen carriers for enhanced diabetic wound-healing therapy. Int J Nanomedicine. 2019;14:5449–5475. doi:10.2147/IJN.S21388331409998
   PubMed Web of Science ®Google Scholar
• Tummala S, Gowthamarajan K, Satish Kumar MN, et al. Formulation and optimization of oxaliplatin immuno-nanoparticles using Box-Behnken design and cytotoxicity assessment for synergistic and receptor-mediated targeting in the treatment of colorectal cancer. Artif Cells Nanomed Biotechnol. 2016;44(8):1835–1850. doi:10.3109/21691401.2015.111122626697734
   PubMed Web of Science ®Google Scholar
• Han F, Li SM, Yin R, Liu HZ, Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloid Surf A. 2008;315(1–3):210–216. doi:10.1016/j.colsurfa.2007.08.005
   Web of Science ®Google Scholar
• Ferreira M, Chaves LL, Lima SA, Reis S. Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy. Int J Pharm. 2015;492(1–2):65–72. doi:10.1016/j.ijpharm.2015.07.01326169145
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm. 2007;67(1):141–148. doi:10.1016/j.ejpb.2007.01.01517346953
   PubMed Web of Science ®Google Scholar
• Uchida T, Kadhum WR, Kanai S, Todo H, Oshizaka T, Sugibayashi K. Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M. Eur J Pharm Sci. 2015;67:113–118. doi:10.1016/j.ejps.2014.11.00225447745
   PubMed Web of Science ®Google Scholar
• Yun YE, Jung YJ, Choi YJ, Choi JS, Cho YW. Artificial skin models for animal-free testing. J Pharm Investig. 2018;48(2):215–223. doi:10.1007/s40005-018-0389-1
   Google Scholar
• Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001;52(2):103–112.11522474
   PubMed Web of Science ®Google Scholar
• Hajjar B, Zier K-I, Khalid N, Azarmi S, Löbenberg R. Evaluation of a microemulsion-based gel formulation for topical drug delivery of diclofenac sodium. J Pharm Investig. 2018;48(3):351–362. doi:10.1007/s40005-017-0327-7
   Google Scholar
• Mbah CC, Builders PF, Agubata CO, Attama AA. Development of ethosomal vesicular carrier for topical application of griseofulvin: effect of ethanol concentration. J Pharm Investig. 2019;49(1):27–36. doi:10.1007/s40005-017-0367-z
   Google Scholar
• Morales JO, Valdes K, Morales J, Oyarzun-Ampuero F. Lipid nanoparticles for the topical delivery of retinoids and derivatives. Nanomedicine-Uk. 2015;10(2):253–269. doi:10.2217/nnm.14.159
   PubMed Web of Science ®Google Scholar
• Khurana S, Bedi PMS, Jain NK. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phys Lipids. 2013;175:65–72. doi:10.1016/j.chemphyslip.2013.07.01023994283
   PubMed Web of Science ®Google Scholar
• MagalhãesI MSF, FechineII FV, de MacedoIII RN, et al. Effect of a combination of medium chain triglycerides, linoleic acid, soy lecithin and vitamins A and E on wound healing in rats1. Acta Cirúrgica Brasileira. 2008;23:3.
   Web of Science ®Google Scholar